 David Mead, Ph.D., Founder, Chief Executive Officer. Dr. Mead has 20 years of industrial experience in R&D, sales, and management at leading biotechnology companies, including Bio-Rad, Promega, Molecular Biology Resources, Key Scientific and Chimerx. In 1998 he founded Lucigen. Dr. Mead is a recognized expert in gene cloning and genomics. He has published 20 professional articles, holds four patents, and has written over 50 commercial articles in basic and applied molecular biology. He has developed more than 30 commercially successful products, including the TA cloning vectors and kits which are the world’s most widely used cloning tools now manufactured by Invitrogen Corporation. Dr. Mead is also the founder and CEO of C5•6, a Lucigen spin-off in August 2006. |
 Jeffrey Williams, Ph.D., President. Dr. Williams joined Lucigen as President, and brings over 20 years of relevant experience, having previously held senior level management positions at leading life science and diagnostic companies. He comes to Lucigen from Platypus Technologies where he was President and CEO. Jeff has also held Vice President positions at Roche Diagnostics, Ambion, and Asuragen where he focused on operations and product and business development. He holds a B.S. in Biochemistry and a Ph.D. in Pharmaceutical Biochemistry from the University of Wisconsin-Madison. |
pany